Maximus Q3 FY2026 earnings: Efficiency lifts margins despite lower revenue
Maximus (NYSE: MMS) reported fiscal Q3 2026 revenue of $1.28 billion, down about 5.2% from $1.35 billion a year earlier, while GAAP diluted EPS increased 4.8% to $1.95 from $1.86. Efficiency initiatives supported higher margins, but delayed customer collections contributed to negative quarterly free cash flow, and a temporary federal contract modification led Maximus to update its full-year earnings and cash flow outlook.
Core financial results
The revenue decline primarily reflected a difficult comparison in U.S. Federal Services, where the prior-year quarter benefited from elevated natural-disaster response activity and temporary clinical volume surges. Gross profit and operating income also declined, but by less than revenue, allowing both gross and operating margins to improve.
GAAP net income decreased 2.3%, while diluted EPS rose because the weighted-average diluted share count fell about 6.9%. Adjusted diluted EPS also increased, although adjusted EBITDA declined by approximately 3.0%.
| Metric | Fiscal Q3 2026 | Fiscal Q3 2025 | Year-over-year change |
|---|---|---|---|
| Revenue | $1.279 billion | $1.348 billion | Down 5.2% |
| Gross profit | $348.8 million | $359.5 million | Down 3.0% |
| Gross margin | 27.3% | 26.7% | Up about 0.6 percentage points |
| Operating income | $161.4 million | $165.7 million | Down 2.6% |
| Operating margin | 12.6% | 12.3% | Up 0.3 percentage points |
| Net income | $103.6 million | $106.0 million | Down 2.3% |
| Diluted EPS | $1.95 | $1.86 | Up 4.8% |
| Adjusted diluted EPS | $2.22 | $2.16 | Up 2.8% |
| Adjusted EBITDA | $192.3 million, 15.0% margin | $198.3 million, 14.7% margin | Down 3.0%; margin up 0.3 points |
| Free cash flow | $(137.0) million | $(198.2) million | Outflow narrowed by $61.2 million |
Adjusted diluted EPS, adjusted EBITDA and free cash flow are non-GAAP measures. Other figures are GAAP unless otherwise indicated.
Business and segment performance
Revenue declined across all three segments, but profitability trends diverged. U.S. Federal Services and U.S. Services expanded their operating margins, while the Outside the U.S. segment experienced a material margin contraction.
| Segment | Q3 2026 revenue | Q3 2025 revenue | Revenue change | Q3 2026 operating margin | Q3 2025 operating margin |
|---|---|---|---|---|---|
| U.S. Federal Services | $721.0 million | $761.2 million | Down about 5.3% | 18.6% | 18.1% |
| U.S. Services | $418.2 million | $439.8 million | Down about 4.9% | 10.8% | 10.2% |
| Outside the U.S. | $139.8 million | $147.4 million | Down about 5.2% | 0.9% | 4.0% |
Federal Services benefited from productivity improvements, technology-enabled efficiencies and stable core-program performance. Its revenue decline was largely attributable to the prior-year disaster response and clinical volumes that did not recur at the same level.
U.S. Services continued to improve sequentially during fiscal 2026, according to the company, although revenue remained below the prior-year quarter. Outside the U.S. was the main profitability weak point: changing volumes across clinical and employment-services contracts reduced revenue, while operating income fell to $1.2 million from $5.9 million.
At June 30, 2026, Maximus had $1.25 billion of year-to-date signed contract awards and $1.35 billion of awarded but unsigned contracts. Its sales pipeline totaled $50.4 billion, with new-work opportunities representing approximately 57% and Federal Services accounting for about 55%.
Efficiency protected earnings, but receivables weighed on cash flow
Maximus expanded margins despite lower revenue through efficiency initiatives that included broader use of automation and AI-enabled tools. Selling, general and administrative expenses decreased to $167.2 million from $170.8 million, and intangible-asset amortization declined to $20.2 million from $23.0 million. A lower diluted share count also allowed EPS to increase even though net income declined.
Cash conversion remained the main counterpoint. Operating activities used $125.0 million of cash, largely reflecting a $266.7 million quarterly increase in accounts receivable within the cash flow statement. Free cash outflow improved from the prior year but remained negative at $137.0 million.
Accounts receivable reached $1.38 billion at June 30, up from $898.1 million at the September 2025 fiscal year-end, while days sales outstanding reached 98 days. Maximus said collections from a major federal customer accelerated in July and continued to expect fiscal year-end DSO below 70 days.
Nine-month free cash flow was an outflow of $208.6 million. Based on the full-year guidance, Maximus would need to generate approximately $634 million to $684 million of free cash flow in the fourth quarter to reach its fiscal 2026 target, making customer collection timing particularly important.
Unrestricted cash totaled $57 million and gross debt was $1.65 billion. Net leverage was 2.0 times trailing consolidated EBITDA, up from 1.8 times at March 31 but still within the company’s target range of 2 to 3 times. Maximus also repurchased approximately 0.75 million shares for $50.4 million during the quarter.
Fiscal 2026 guidance
Maximus reiterated its fiscal 2026 revenue range but now expects results toward the lower end. Earnings and free cash flow guidance were updated to reflect a customer-directed contractual modification affecting a major federal program from July 1 through December 31, 2026.
| Metric | Latest fiscal 2026 outlook | Management update |
|---|---|---|
| Revenue | $5.2 billion to $5.35 billion | Reiterated; results expected toward the lower end |
| Adjusted diluted EPS | $7.90 to $8.20 | Updated for the temporary contract modification |
| Adjusted EBITDA margin | Approximately 13.7% | Updated for the contract modification |
| Free cash flow | $425 million to $475 million | Updated in line with the earnings change |
| U.S. Federal Services operating margin | 16.5% to 17.0% | Reflects the temporary modification |
| U.S. Services operating margin | 9.5% to 10.0% | Full-year expectation maintained |
The company also expects fiscal 2026 interest expense of $88 million and a tax rate of 24.0% to 24.5%.
Management perspective
President and CEO Bruce Caswell attributed the quarter’s earnings performance to disciplined execution and efficiency improvements. Management also reported encouraging demand signals, increased adoption of AI-enabled solutions, growing interest in SNAP-related offerings and opportunities in defense and national security markets.
The immediate operational focus is balancing those longer-term opportunities with the temporary federal contract change and converting the Outside the U.S. sales pipeline into revenue and improved profitability.
Recent insider transactions
The supplied six-month insider summary reports 97,481 shares purchased and 742 shares sold, resulting in net purchases of 96,739 shares. The latest individual records include one open-market sale, several grants and gifts, and a $249,081 purchase by CEO Bruce Caswell.
| Date | Insider | Role | Transaction | Reported value |
|---|---|---|---|---|
| Mar. 17, 2026 | Jan D. Madsen | Director | Sale, direct | $53,610 |
| Mar. 10, 2026 | John J. Haley | Director | Stock award, direct | $0 |
| Mar. 10, 2026 | Jan D. Madsen | Director | Stock award, direct | $0 |
| Mar. 10, 2026 | Anne K. Altman | Director | Stock award, direct | $0 |
| Mar. 10, 2026 | Michael J. Warren | Director | Stock award, direct | $0 |
| Mar. 10, 2026 | Gayathri Rajan | Director | Stock award, direct | $0 |
| Feb. 27, 2026 | Richard A. Montoni | Director | Stock gift, indirect | $0 |
| Feb. 24, 2026 | Richard A. Montoni | Director | Stock gift, indirect | $0 |
| Feb. 18, 2026 | John J. Haley | Director | Stock gift, indirect | $0 |
| Feb. 10, 2026 | Bruce L. Caswell | CEO | Purchase, direct | $249,081 |
The $0 reported values relate to awards or gifts and should not be interpreted as open-market transaction prices. Individual transactions alone do not establish an insider’s view of the company’s prospects.
Risks investors should watch
- Federal contract profitability: The temporary modification to a major federal program has already affected fiscal 2026 earnings and margin guidance. Its financial impact is concentrated in Maximus’s largest segment.
- Cash collection timing: DSO of 98 days and negative nine-month free cash flow leave the full-year cash target dependent on substantial fourth-quarter collections.
- Outside the U.S. profitability: The segment’s operating margin fell to 0.9% from 4.0%. Achieving the company’s fiscal 2026 break-even objective depends partly on converting its sales pipeline and improving program performance.
- Continued revenue pressure: All three segments reported year-over-year revenue declines, and management expects full-year consolidated revenue toward the lower end of its unchanged range.
Summary
Maximus’s fiscal Q3 2026 results showed that efficiency measures and a lower share count could support margins and EPS even as revenue declined. The main near-term issues are the profitability impact of the federal contract modification and the conversion of elevated receivables into cash, while segment pipeline conversion and improvement outside the U.S. remain important operating priorities.
This article may include AI-generated content that is human-reviewed, which is for reference and general information purposes only and does not constitute investment advice.
Recommended Articles








Comments (0)
Click the $ button, enter the symbol, and select to link a stock, ETF, or other ticker.